Table 1.
Pharmacologic Treatment | BaselineYBOCS Score | YBOCS ScoreAfter rTMS | YBOCS Score After rTMS (12-wk follow-up) |
||||||
Group and Patients | 2wk | 4 wk | 6 wk | 8 wk | 10 wk | 12 wk | |||
Active rTMS | |||||||||
1 | Fluvoxamine | 36 | 34 | 34 | 34 | 33 | 33 | 33 | 33 |
2 | Venlafaxine, risperidone | 26 | 18 | 19 | 22 | 19 | 19 | 19 | 19 |
3 | Fluvoxamine | 25 | 15 | 15 | 15 | 15 | 15 | 15 | 15 |
4 | Fluvoxamine | 32 | 30 | 30 | 30 | 30 | 30 | 30 | 30 |
5 | Fluoxetine | 37 | 24 | 27 | 29 | 27 | 25 | 25 | 25 |
6 | Fluvoxamine, paroxetine | 28 | 17 | 17 | 17 | 17 | 17 | 16 | 16 |
7 | Fluvoxamine, clomipramine, risperidone | 31 | 21 | 21 | 21 | 21 | 21 | 21 | 21 |
8 | Clomipramine | 34 | 34 | 34 | 34 | 34 | 34 | 34 | 34 |
9 | Fluvoxamine | 31 | 28 | 28 | 28 | 28 | 28 | 28 | 28 |
10 | Clomipramine | 39 | 36 | 35 | 40 | 40 | 40 | 39 | 39 |
11 | Sertraline | 16 | 10 | 6 | 6 | 6 | 6 | 6 | 6 |
12 | Clomipramine, risperidone | 34 | 25 | 25 | 25 | 25 | 25 | 30 | 30 |
13 | Fluvoxamine | 38 | 33 | 33 | 33 | 34 | 34 | 34 | 34 |
14 | Clomipramine | 36 | 24 | 12 | 12 | 12 | 20 | 28 | 36 |
15 | Fluvoxamine | 38 | 36 | 36 | 36 | 36 | 36 | 36 | 36 |
16 | Fluvoxamine | 34 | 33 | 33 | 34 | 34 | 34 | 34 | 34 |
Sham rTMS | |||||||||
17 | Venlafaxine | 26 | 26 | 26 | 26 | 26 | 26 | 26 | 26 |
18 | Fluvoxamine, clomipramine | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 |
19 | Clomipramine | 28 | 28 | 28 | 28 | 28 | 28 | 28 | 28 |
20 | Clomipramine, risperidone | 37 | 37 | 37 | 37 | 37 | 37 | 37 | 37 |
21 | Clomipramine | 29 | 24 | 24 | 29 | 24 | 24 | 29 | 24 |
22 | Fluvoxamine | 40 | 40 | 40 | 40 | 40 | 40 | 40 | 40 |
23 | Fluoxetine | 38 | 28 | 28 | 30 | 30 | 28 | 30 | 30 |
Abbreviation: YBOCS = Yale-Brown Obsessive Compulsive Scale.